CSIMarket Company Name, Ticker, Industry, else..
 
Integrated Biopharma Inc  (INBP)
Other Ticker:  
 
 

Integrated Biopharma Inc Growth Comparisons

Select each growth Category to receive further Information



INBP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 4.11 % -4.78 % - -0.4 %
Q / Q Revenue Growth (Q3 MRQ) 3.63 % -0.64 % - 1.05 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) -9.41 % -5.31 % - %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 1.01 % -1.28 % - 0.08 %
Revenue 5 Year Average Growth 2.75 % 40.52 % 9.72 % 9.23 %


INBP's Growth Comparisons in I. Quarter 2023




Integrated Biopharma Inc managed to grow Revenue by 4.11% year on year, in the first quarter 2023 to 13 millions, while Major Pharmaceutical Preparations industry fell by -4.78%, Healthcare sector remained unchanged %. Despite modest Sales in the Healthcare sector and the Major Pharmaceutical Preparations industry, Integrated Biopharma Inc reported above average market Sales growth.

Comparing the company's Revenue to the forth quarter results, sales were higher by 3.63% . On the yearly basis, average annual sales growth for Integrated Biopharma Inc is 2.75%, while S & P 500's including only Businesses with the first quarter 2023 earnings, average annual sales growth is 9.23% over the past five years.


Growth Rates of INBP's Income in the first quarter 2023


INBP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - -44.62 % -41.06 % 0.85 %
Seq. Operating Income Change (Q3 MRQ) - 43.84 % 40.92 % 9.07 %
Y / Y Operating Income Growth (Q3 TTM) -98.36 % -24.01 % -26.13 % -9.2 %
Seq. Operating Income Growth (Q3 TTM) -70 % -13.69 % -12.21 % -0.5 %
Operating Income 5 Year Avg. Change -41.11 % 38.2 % 5.12 % 7.04 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - -63.85 % -78.35 % 1.97 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 82.68 % 611.57 % 12.5 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - -58.03 % -57.21 % -8.98 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - -30.4 % -33.11 % -0.12 %
Income from Cont. Ops. 5 Year Avg. Change - 20.65 % 9.98 % 9.06 %

INBP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 28.01 % 8.01 % 7.9 %
Q / Q Net Income Growth (Q3 MRQ) - 586.15 % 3746.45 % 16.86 %
Y / Y Net Income Change (Q3 TTM) - -30.24 % -31.5 % -6.63 %
Seq. Net Income Change (Q3 TTM) - 13.64 % 4.46 % 1.48 %
Net Income 5 Year Avg. Growth - 20.06 % 9.64 % 9.91 %

INBP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - -54.6 % -78.35 % 1.97 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 80.26 % 611.57 % 12.5 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) -73.88 % - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 0 % - - 117.28 %
EPS from Cont. Ops. 5 Year Avg. Growth - -4.8 % 9.98 % 9.06 %



INBP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - 60.77 % 8.01 % 9.06 %
Q / Q EPS Net Growth (Q3 MRQ) - 577.04 % 3746.45 % 16.86 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 64457.82 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 0 % - - 115.81 %
EPS Net 5 Year Avg. Change - 20.06 % 9.64 % 9.91 %



Integrated Biopharma Inc reported bottom-line of $ 0.00 in the first quarter, compare to $ 0.00 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 60.77%, while Healthcare sector increased by 8.01%, and overall market improved by 7.9%.

Comparing company's EPS to the forth quarter results, income per share were higher by 3.63% . On the yearly basis, average annual income per share growth for Integrated Biopharma Inc is 2.75%, while S & P 500's including only the businesses with the first quarter 2023 Results, average annual income per share growth is 9.91% over the past five years.

INBP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 32.36 % 10.94 % 4.77 % 23.64 %
Seq. Free Cash Flow Change (Q3 MRQ) - 112.53 % 54.53 % 31.16 %
Y / Y Free Cash Flow Change (Q3 TTM) -47.92 % -9.62 % -8.94 % -4.38 %
Seq. Free Cash Flow Change (Q3 TTM) 26.06 % 4.06 % 2.54 % 8.08 %
Free Cash Flow 5 Year Avg. Change 3.8 % 110.95 % 22.37 % 8.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) 52.69 % 22.95 % 49.72 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) 28.35 % - - -
Seq. Net Cash Flow Change (Q3 TTM) - 2166.69 % 23.61 % -
Net Cash Flow 5 Year Avg. Change 59.31 % 144.73 % - 242.36 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -24 % 7.27 % 4.29 % 66.58 %
Seq. Capital Expenditures Change (Q3 MRQ) 111.11 % 6.69 % 4.82 % 16.84 %
Y / Y Capital Expenditures Change (Q3 TTM) -74.32 % 7.95 % 4.93 % -10.03 %
Seq. Capital Expenditures Change (Q3 TTM) -10.34 % 1.41 % 1.16 % 11.24 %
Capital Expenditures 5 Year Avg. Change -14.03 % 80.89 % 13.78 % 7.19 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com